Literature DB >> 23956438

Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.

Peter V Aka1, Mark H Kuniholm, Ruth M Pfeiffer, Alan S Wang, Wei Tang, Sabrina Chen, Jacquie Astemborski, Michael Plankey, Maria C Villacres, Marion G Peters, Seema Desai, Eric C Seaberg, Brian R Edlin, Howard D Strickler, David L Thomas, Ludmila Prokunina-Olsson, Gerald B Sharp, Thomas R O'Brien.   

Abstract

Interferon lambda 4 protein can be generated in IFNL4-ΔG carriers but not IFNL4-TT homozygotes. We studied 890 anti-hepatitis C virus (HCV)-positive participants in the Women's Interagency HIV Study. Among blacks (n = 555), HCV was more often cleared for those with genotype IFNL4-TT/TT (32.6%; odds ratio [OR], 3.59; P = 3.3 × 10(-5)) than IFNL4-TT/ΔG (11.3%; OR, 0.95; P = .86) or IFNL4-ΔG/ΔG (11.9%; referent). Pooling these data with published results in blacks (n = 1678), ORs were 3.84 (P = 8.6 × 10(-14)) for IFNL4-TT/TT and 1.44 (P = .03) IFNL4-TT/ΔG, and the area under the curve was 0.64 for IFNL4-ΔG genotype and 0.61 for rs12979860 (IL28B). IFNL4-ΔG is strongly associated with impaired spontaneous HCV clearance.

Entities:  

Keywords:  HCV; IFNL4; IL28B; genetic; viral clearance

Mesh:

Substances:

Year:  2013        PMID: 23956438      PMCID: PMC3883162          DOI: 10.1093/infdis/jit433

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002).

Authors: 
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 2.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association.

Authors:  Fatma M Shebl; Ruth M Pfeiffer; Dianna Buckett; Brian Muchmore; Sabrina Chen; Myhanh Dotrang; Ludmila Prokunina-Olsson; Brian R Edlin; Thomas R O'Brien
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

4.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.

Authors:  Ludmila Prokunina-Olsson; Brian Muchmore; Wei Tang; Ruth M Pfeiffer; Heiyoung Park; Harold Dickensheets; Dianna Hergott; Patricia Porter-Gill; Adam Mumy; Indu Kohaar; Sabrina Chen; Nathan Brand; McAnthony Tarway; Luyang Liu; Faruk Sheikh; Jacquie Astemborski; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Timothy R Morgan; David L Thomas; Barbara Rehermann; Raymond P Donnelly; Thomas R O'Brien
Journal:  Nat Genet       Date:  2013-01-06       Impact factor: 38.330

Review 5.  IL28B and the control of hepatitis C virus infection.

Authors:  Ashwin Balagopal; David L Thomas; Chloe L Thio
Journal:  Gastroenterology       Date:  2010-10-13       Impact factor: 22.682

6.  HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations.

Authors:  Lorenzo Uccellini; Fan-Chen Tseng; Alessandro Monaco; Fatma M Shebl; Ruth Pfeiffer; Myhanh Dotrang; Dianna Buckett; Michael P Busch; Ena Wang; Brian R Edlin; Francesco M Marincola; Thomas R O'Brien
Journal:  Hepatology       Date:  2012-06-01       Impact factor: 17.425

7.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

Review 8.  Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.

Authors:  Khayriyyah Mohd Hanafiah; Justina Groeger; Abraham D Flaxman; Steven T Wiersma
Journal:  Hepatology       Date:  2013-02-04       Impact factor: 17.425

9.  IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.

Authors:  Stéphanie Bibert; Thierry Roger; Thierry Calandra; Murielle Bochud; Andreas Cerny; Nasser Semmo; François H T Duong; Tilman Gerlach; Raffaele Malinverni; Darius Moradpour; Francesco Negro; Beat Müllhaupt; Pierre-Yves Bochud
Journal:  J Exp Med       Date:  2013-05-27       Impact factor: 14.307

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

  10 in total
  50 in total

1.  Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.

Authors:  Eric G Meissner; David Wu; Anu Osinusi; Dimitra Bon; Kimmo Virtaneva; Dan Sturdevant; Steve Porcella; Honghui Wang; Eva Herrmann; John McHutchison; Anthony F Suffredini; Michael Polis; Stephen Hewitt; Ludmila Prokunina-Olsson; Henry Masur; Anthony S Fauci; Shyamasundaran Kottilil
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

2.  Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential.

Authors:  Thomas R O'Brien; Howard A Young; Raymond P Donnelly; Ludmila Prokunina-Olsson
Journal:  J Interferon Cytokine Res       Date:  2019-04-17       Impact factor: 2.607

3.  HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.

Authors:  B Dominguez-Molina; L Tarancon-Diez; S Hua; C Abad-Molina; E Rodriguez-Gallego; K Machmach; F Vidal; C Tural; S Moreno; J M Goñi; E Ramírez de Arellano; M Del Val; M F Gonzalez-Escribano; J Del Romero; C Rodriguez; L Capa; P Viciana; J Alcamí; X G Yu; B D Walker; Manuel Leal; M Lichterfeld; E Ruiz-Mateos
Journal:  Clin Infect Dis       Date:  2016-12-16       Impact factor: 9.079

4.  Nonalcoholic fatty liver disease: is the IFNL4 rs368234815 variant protective from liver damage?

Authors:  Enrico Galmozzi; Roberta D'Ambrosio
Journal:  Hepatobiliary Surg Nutr       Date:  2018-06       Impact factor: 7.293

5.  Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico.

Authors:  Lilliana Morales-Vásquez; Edgar I Miranda-Avalo; José R Rodríguez-Medina; Yomarid Quiñones-Badillo; Juan Marqués-Lespier; José Muñoz-Acabá; Rafael Pastrana; Cynthia M Pérez-Cardona; Yasuhiro Yamamura; Esther A Torres
Journal:  P R Health Sci J       Date:  2014-12       Impact factor: 0.705

6.  Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.

Authors:  Thomas R O'Brien; Ruth M Pfeiffer; Ashley Paquin; Krystle A Lang Kuhs; Sabrina Chen; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Gregory D Kirk; Mark H Kuniholm; Timothy R Morgan; Howard D Strickler; David L Thomas; Ludmila Prokunina-Olsson
Journal:  J Hepatol       Date:  2015-07-15       Impact factor: 25.083

Review 7.  What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?

Authors:  Thomas R O'Brien; Sarah S Jackson
Journal:  J Interferon Cytokine Res       Date:  2019-06-04       Impact factor: 2.607

Review 8.  IFN-λ4: the paradoxical new member of the interferon lambda family.

Authors:  Thomas R O'Brien; Ludmila Prokunina-Olsson; Raymond P Donnelly
Journal:  J Interferon Cytokine Res       Date:  2014-04-30       Impact factor: 2.607

9.  IFNL4 haplotype, linkage disequilibrium and their influence on virological response to hepatitis C virus infection in Indian population.

Authors:  Neelanjana Roy; Chandreswar Prasad; Anand Kumar; Krishnendu Mondol; Kajal Jain; Renu Yadav; Jyotish Kumar Jha; Neeti Nadda; Subrat Kumar Acharya; Baibaswata Nayak
Journal:  Virusdisease       Date:  2019-07-24

Review 10.  Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.

Authors:  Sreedhar Chinnaswamy
Journal:  J Interferon Cytokine Res       Date:  2014-02-20       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.